13F-HR filed by Foresite Capital Management VI LLC
Foresite Capital Management VI LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 23 holding rows worth $642,575,985.
- Accession
- 0001104659-26-097133
- Filer
- CIK 2013341
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 23 entries on the cover page, a total value of $642,575,985 stated on the cover page (in dollars after the unit check, H1), rows summing to $642,575,985 with VALUE read as dollars as filed, 13F file number 028-25267. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 2,369,574 | $168,358,233 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 4,247,670 | $119,529,434 | dollars as filed | |
| SEAPORT THERAPEUTICS INC | 81221K108 | COMMON STOCK | 1,779,521 | $38,651,196 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,396,771 | $35,924,950 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 879,713 | $32,734,121 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 785,000 | $29,131,350 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,831,233 | $27,358,621 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 999,044 | $27,343,834 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 940,493 | $25,280,452 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 886,667 | $19,701,741 | dollars as filed | |
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 220,400 | $18,293,200 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 146,332 | $16,779,890 | dollars as filed | |
| ATAIBECKLEY INC | 04650F101 | COM SHS | 2,750,000 | $14,492,500 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 3,146,631 | $12,020,130 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 330,000 | $11,325,600 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,985,584 | $11,019,991 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 301,341 | $10,468,586 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 1,333,334 | $9,466,671 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 212,010 | $7,933,414 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 300,000 | $3,210,000 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 450,000 | $2,655,000 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 37,500 | $826,125 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 970 | $70,946 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-097133 | this filing | 2026-08-14 | acceptance time not in the bulk data set |